Royal Bank Of Canada Begins Coverage on Hinge Health (NYSE:HNGE)

Stock analysts at Royal Bank Of Canada started coverage on shares of Hinge Health (NYSE:HNGE) in a research report issued on Monday, MarketBeat reports. The firm set an “outperform” rating and a $45.00 price target on the stock. Royal Bank Of Canada’s price target would suggest a potential upside of 19.78% from the stock’s current price.

Several other equities research analysts have also commented on the stock. Wall Street Zen upgraded shares of Hinge Health to a “hold” rating in a report on Monday, June 2nd. Barclays began coverage on shares of Hinge Health in a research note on Monday. They issued an “overweight” rating and a $43.00 price objective for the company. Bank of America assumed coverage on Hinge Health in a report on Monday. They issued a “buy” rating and a $42.00 price target on the stock. Canaccord Genuity Group assumed coverage on Hinge Health in a research note on Monday. They set a “buy” rating and a $52.00 price objective for the company. Finally, KeyCorp started coverage on Hinge Health in a research note on Monday. They issued an “overweight” rating and a $45.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $46.00.

Hinge Health Stock Performance

HNGE stock opened at $37.57 on Monday. Hinge Health has a 1-year low of $33.42 and a 1-year high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.